Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

Novo Nordisk said its diabetes pill Rybelsus showed cardiovascular benefits in a late ... Both treatments, as well as the company's weekly weight loss injection Wegovy, contain the active ingredient ...

Rybelsus reduced the risk of cardiovascular-related death, heart attack, and stroke by 14% compared to a placebo over an ...

India's anti-obesity drug market shows significant growth. It has increased fourfold in five years. Lifestyle diseases and ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular ... Both treatments, as well as the company's weekly weight loss injection Wegovy, contain the active ingredient ...